ZYUS
Saskatoon
About ZYUS
ZYUS is a biopharmaceutical company that offers patients cannabinoids and other phytotherapeutic medical solutions. The company elevates cannabinoids as a medical solution to alleviate suffering in patients who are experiencing discomfort due to chronic disease, treatment side effects, or conditions related to aging. It aims is to shift the paradigm from the treatment of physical disease to caring for overall well-being, by accelerating the adoption of phytotherapeutics. The company uses science as a driver to establish phytotherapeutics as a standard of care for treating disease and managing the experience of it. The company was founded in 2018 and is headquartered in Saskatoon, Saskatchewan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $40.8M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2026)
- Ticker: cve:ZYUS
- Website: zyus.com
- Phone: (306) 242-2357
Industries & Categories
Biopharma, Biotechnology, Cannabis, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/zyus-92729 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.